Equities

Asensus Surgical Inc

Asensus Surgical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.25
  • Today's Change0.001 / 0.40%
  • Shares traded688.12k
  • 1 Year change-60.94%
  • Beta1.4453
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.

  • Revenue in USD (TTM)8.58m
  • Net income in USD-78.43m
  • Incorporated1988
  • Employees207.00
  • Location
    Asensus Surgical Inc1 TW ALEXANDER DRIVE, SUITE 160DURHAM 27703United StatesUSA
  • Phone+1 (919) 765-8400
  • Fax+1 (302) 655-5049
  • Websitehttps://asensus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beyond Air Inc689.00k-66.70m49.11m98.00--1.82--71.28-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Vaso Corp81.02m4.81m49.62m300.009.431.858.550.61240.030.030.46260.15311.1020.686.03270,080.006.527.6011.1916.6262.4458.395.935.821.45--0.0043--2.181.84-57.46---22.33--
Heartbeam Inc0.00-14.64m53.97m15.00--3.39-----0.9404-0.94040.000.60530.00----0.00-138.30---159.89--------------0.00-------12.94------
Icecure Medical Ltd3.23m-14.65m54.88m71.00--4.51--16.99-0.3211-0.32110.07080.2660.13860.751835.6845,478.88-62.89-54.89-76.33-68.6640.2649.87-453.76-313.193.08--0.00--4.6723.5013.70--48.10--
Sensus Healthcare Inc24.41m485.00k55.58m35.00116.301.1473.132.280.02920.02921.502.980.4421.131.75697,314.300.878310.290.984412.1457.6162.851.9915.298.23--0.00---45.20-1.58-98.00---23.16--
Medinotec Inc3.05m-566.90k58.67m29.00--28.27--19.24-0.0483-0.04830.25980.17690.67122.0616.96105,130.70-12.48---13.23--53.56---18.59--8.571.440.4323---3.91---184.47------
Hyperfine Inc11.03m-44.24m59.00m131.00--0.6985--5.35-0.6205-0.62050.15471.170.09671.124.1784,213.74-38.76---42.00--43.12---401.00--9.39--0.00--61.90--39.54------
Vivos Inc19.50k-2.89m60.90m10.00--44.70--3,123.04-0.0079-0.00790.000050.00350.0116--2.17---172.67-202.25-191.32-552.77-30.9710.79-14,844.92-11,969.07----0.00---46.58---17.19------
Autonomix Medical Inc0.00-10.68m62.40m3.00---------0.5055-0.50550.00-0.2649------0.00----------------------------84.50------
IR-MED Inc0.00-4.91m62.94m6.00--172.43-----0.0714-0.07140.000.00520.00----0.00-228.70---310.89--------------0.3061-------3.70------
Pro-Dex Inc48.24m5.00m64.61m146.0013.232.0510.691.341.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Asensus Surgical Inc8.58m-78.43m68.00m207.00--1.98--7.93-0.3162-0.31620.03440.12610.0981.702.9841,434.78-89.57-71.10-103.14-79.04-53.38-71.39-914.46-1,207.712.31--0.00--21.02-18.67-3.80---6.14--
Alpha Pro Tech, Ltd.61.23m4.19m69.69m124.0017.161.1313.631.140.35430.35435.165.390.91691.7211.25493,814.506.2715.216.5216.0637.2840.236.8412.9312.83--0.000.00-1.215.6027.642.935.50--
Monogram Orthopaedics Inc365.00k-13.75m71.09m28.00------194.76-0.4621-0.46210.0123--0.0241----13,035.71-90.82-119.26-149.39-257.400.00---3,765.81-5,045.60----0.00-------0.3964---15.97--
DIH Holding US Inc60.30m-1.77m72.58m--------1.20-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Data as of Apr 30 2024. Currency figures normalised to Asensus Surgical Inc's reporting currency: US Dollar USD

Institutional shareholders

8.85%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202311.50m4.23%
BlackRock Fund Advisorsas of 31 Dec 20233.46m1.27%
Geode Capital Management LLCas of 31 Dec 20232.40m0.88%
Olympia Wealth Management Ltd.as of 28 Mar 20242.00m0.74%
Masters Capital Management LLCas of 31 Dec 20232.00m0.74%
SSgA Funds Management, Inc.as of 31 Dec 2023952.93k0.35%
UBS Securities LLCas of 31 Dec 2023694.90k0.26%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023495.38k0.18%
Contego Capital Group, Inc.as of 29 Dec 2023300.00k0.11%
Woodbury Financial Services, Inc.as of 31 Dec 2023276.94k0.10%
More ▼
Data from 29 Dec 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.